Novartis announced today the early termination of the ALTITUDE trial, which was testing the effect of the direct renin inhibitor aliskiren (Rasilez, Tekturna) in type 2 diabetics at high risk for ...

New York, NY - Doubts about the effectiveness of the new renin inhibitor antihypertensive aliskiren (Tektura, Novartis) have been voiced in a somewhat controversial review article in the May 2007 ...

San Diego, CA - Cardiorenal results from the multicenter Aliskiren Trial in Type 2 Diabetes Using Cardio-Renal Endpoints (ALTITUDE) trial, testing aliskiren (Tekturna, Novartis Pharmaceuticals) as an ...

Last December the once-promising direct renin inhibitor aliskiren (Rasilez, Tekturna) suffered a fatal setback with the early termination of the ALTITUDE trial. The trial was stopped when the Data ...

Learn everything you need to know about Aliskiren and Hydrochlorothiazide-pronunciation, uses, dosage guidelines, indications, and when to take or avoid it. Get up-to-date information on side effects, ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Patients with type 2 diabetes and chronic kidney disease ...

Diabetic nephropathy is the leading cause of end-stage renal disease in developed countries. We evaluated the renoprotective effects of dual blockade of the renin−angiotensin−aldosterone system by ...

ECS: Aliskiren Doesn’t Slow Progression of Atherosclerosis For patients with coronary artery disease and prehypertension, aliskiren is not associated with improvement or slowing of coronary ...

The alternative text for this image may have been generated using AI. The randomization list was generated by the interactive voice response system provider with a validated system that automated the ...

The first evidence of the existence of renin was presented by Tigerstedt over 100 years ago. However, the importance of renin and the renin–angiotensin system (RAS) in the pathogenesis of ...

AMSTERDAM, The Netherlands—Aliskiren, a renin inhibitor, does nothing to stall progression of atherosclerosis in prehypertensive patients with coronary artery disease, according to results from the ...

Discover comprehensive details about Aliskiren, including its pronunciation, uses, dosage instructions, indications, and guidelines on how and when to take it or avoid it. The updated prescription ...